Cargando…
A Novel Stimuli‐Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene‐Targeted Therapy towards Uveal Melanoma
Uveal melanoma (UM) is the most prevalent primary intraocular malignant tumor with a high lethal rate. Patients who undergo conventional enucleation treatments consistently suffer permanent blindness, facial defects, and mental disorders, therefore, novel therapeutic modalities are urgently required...
Autores principales: | Wang, Shaoyun, Chen, Baohui, Ouyang, Liping, Wang, Donghui, Tan, Ji, Qiao, Yuqin, Ge, Shengfang, Ruan, Jing, Zhuang, Ai, Liu, Xuanyong, Jia, Renbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456278/ https://www.ncbi.nlm.nih.gov/pubmed/34331418 http://dx.doi.org/10.1002/advs.202004721 |
Ejemplares similares
-
Role of Epigenetics in Uveal Melanoma
por: Li, Yongyun, et al.
Publicado: (2017) -
Injectable Hydrogel for Synergetic Low Dose Radiotherapy, Chemodynamic Therapy and Photothermal Therapy
por: Chen, Mingzhu, et al.
Publicado: (2021) -
Surface defect engineered-Mg-based implants enable the dual functions of superhydrophobic and synergetic photothermal/chemodynamic therapy
por: Zhang, Dongdong, et al.
Publicado: (2023) -
Uveal melanoma: progress in molecular biology and therapeutics
por: Li, Yongyun, et al.
Publicado: (2020) -
Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism
por: Ding, Yi, et al.
Publicado: (2021)